Aktie 688050 EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Eyebright Medical Technology (Beijing) Co., Ltd.

Aktien

688050

CNE1000041J5

688050

Schlusskurs Shanghai S.E.
Andere Börsenplätze
 00:00:00 10.05.2024 		% 5 Tage % 1. Jan.
158 CNY +3,33 % Intraday Chart für Eyebright Medical Technology (Beijing) Co., Ltd. +6,22 % -8,16 %
17.04. Eyebright Medical Technology (Beijing) Co., Ltd. meldet Ergebnis für das erste Quartal zum 31. März 2024 CI
24.02. Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) gibt einen Aktienrückkauf im Wert von CNY 40 Millionen bekannt. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Tranche Update on Eyebright Medical Technology Co., Ltd.'s Equity Buyback Plan announced on February 24, 2024.
Eyebright Medical Technology Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
Eyebright Medical Technology Co., Ltd. authorizes a Buyback Plan.
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Eyebright Medical Technology Co., Ltd.(XSSC:688050) added to S&P Global BMI Index
Eyebright Medical Technology Co., Ltd.(XSSC:688050) added to FTSE All-World Index
Eyebright Medical Technology Plans GDR Issue to Fund Projects, Boost Capital
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Eyebright Medical Technology's Phakic Intraocular Lens Pass Special Review
Eyebright Medical Technology Co., Ltd. agreed to acquire additional 14.1579% stake in Fujian Unicon Optical Co., Ltd from Hong Kong Unicon Optical Co. for CNY 70.1 million.
Certain A Shares of Eyebright Medical Technology Co., Ltd. are subject to a Lock-Up Agreement Ending on 29-JUL-2023.
Fujian Unicon Optical Co., Ltd announced that it expects to receive CNY 175 million in funding from Eyebright Medical Technology Co., Ltd.
IB Settlement Unit in Negotiations to Receive 100 Million Yuan Capital Injection from Eyebright Medical
Fujian Unicon Optical Co., Ltd announced that it expects to receive CNY 100 million in funding from Eyebright Medical Technology Co., Ltd.
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Eyebright Medical Technology Logs 35.3% Jump in 2022 Profit
Eyebright Medical Technology Gets Conditional Nod For Swiss IPO
Eyebright Medical Technology Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 688050 Aktie
  4. Nachrichten Eyebright Medical Technology (Beijing) Co., Ltd.
  5. Andere Sprachen